ResearcherShanxi Bethune Hospital/Tongji Hospital, Tongji Medical College Huazhong University of Science and TechnologyNo recent work listed

Qi Mei

Provisional: name at one institution (moderate confidence)As of 14 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 0
Pancreatic cancer trials: 1 (principal investigator on 1)
Pancreatic cancer grants: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 trial

Trials 1

CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Principal investigator NCT06006390 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Shuang Wei · 1 shared trial, 2023
- Trial CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors NCT06006390 ↗
Jia Wei · 1 shared trial, 2023
- Trial CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors NCT06006390 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.